EyeCon 2026 Banner
|Articles|January 15, 2005

FDA Approves Macugen

The FDA approved pegaptanib sodium injection (Macugen, Eyetech Pharmaceuticals and Pfizer Ophthalmics) for the treatment of neovascular age-related macular degeneration (AMD) on Dec. 17.


Latest CME